Shareholders Equity: The sum of preferred and common equity items.
Parnell Pharmaceuticals Holdings Ltd (PARNF) had Shareholders Equity of $-10.00M for the most recently reported fiscal quarter, ending 2018-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$5.55M |
|
$8.06M |
|
$17.56M |
|
$23.11M |
|
$6.76M |
|
$26.16M |
|
$26.35M |
|
$33.11M |
|
$-10.00M |
|
$-19.45M |
|
|
Shareholders Equity |
$-10.00M |
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|